Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Characterization of mandibular bone in a mouse model of chronic kidney disease.

Lee MM, Chu EY, El-Abbadi MM, Foster BL, Tompkins KA, Giachelli CM, Somerman MJ.

J Periodontol. 2010 Feb;81(2):300-9. doi: 10.1902/jop.2009.090379.

2.

High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.

Lau WL, Linnes M, Chu EY, Foster BL, Bartley BA, Somerman MJ, Giachelli CM.

Nephrol Dial Transplant. 2013 Jan;28(1):62-9. doi: 10.1093/ndt/gfs333. Epub 2012 Oct 8.

3.

The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E.

J Am Soc Nephrol. 2002 Sep;13(9):2299-308.

4.

Estrogen Deficiency Leads to Further Bone Loss in the Mandible of CKD Mice.

Guo Y, Sun N, Duan X, Xu X, Zheng L, Seriwatanachai D, Wang Y, Yuan Q.

PLoS One. 2016 Feb 17;11(2):e0148804. doi: 10.1371/journal.pone.0148804. eCollection 2016 Feb 17.

5.

Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.

Santana AC, Degaspari S, Catanozi S, Dellê H, de Sá Lima L, Silva C, Blanco P, Solez K, Scavone C, Noronha IL.

Nephrol Dial Transplant. 2013 May;28(5):1140-9. doi: 10.1093/ndt/gfs569. Epub 2013 Jan 22.

PMID:
23345625
6.

Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.

Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E.

Kidney Int. 2003 Nov;64(5):1653-61.

7.

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.

Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, Lane N, Slatopolsky E.

Am J Physiol Renal Physiol. 2010 Jun;298(6):F1315-22. doi: 10.1152/ajprenal.00552.2009. Epub 2010 Mar 3.

8.

Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.

Six I, Maizel J, Barreto FC, Rangrez AY, Dupont S, Slama M, Tribouilloy C, Choukroun G, Mazière JC, Bode-Boeger S, Kielstein JT, Drüeke TB, Massy ZA.

Cardiovasc Res. 2012 Oct 1;96(1):130-9. doi: 10.1093/cvr/cvs240. Epub 2012 Jul 20.

PMID:
22822101
9.

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J.

Kidney Int. 2003 Jun;63(6):2020-7.

10.

Normal masticatory function partially protects the rat mandibular bone from estrogen-deficiency induced osteoporosis.

Mavropoulos A, Kiliaridis S, Rizzoli R, Ammann P.

J Biomech. 2014 Aug 22;47(11):2666-71. doi: 10.1016/j.jbiomech.2014.05.012. Epub 2014 May 23.

PMID:
24925255
11.

Hyperbaric oxygen therapy as a prevention modality for radiation damage in the mandibles of mice.

Spiegelberg L, Braks JA, Groeneveldt LC, Djasim UM, van der Wal KG, Wolvius EB.

J Craniomaxillofac Surg. 2015 Mar;43(2):214-9. doi: 10.1016/j.jcms.2014.11.008. Epub 2014 Nov 18.

PMID:
25523397
12.

Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.

El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM.

Kidney Int. 2009 Jun;75(12):1297-307. doi: 10.1038/ki.2009.83. Epub 2009 Mar 25.

13.

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.

Foster BL, Sheen CR, Hatch NE, Liu J, Cory E, Narisawa S, Kiffer-Moreira T, Sah RL, Whyte MP, Somerman MJ, Millán JL.

J Dent Res. 2015 May;94(5):706-14. doi: 10.1177/0022034515573273. Epub 2015 Feb 25.

14.

[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].

Lorenzo Sellares V, Torregrosa V.

Nefrologia. 2008;28 Suppl 3:67-78. Spanish.

15.

Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.

Shuvy M, Abedat S, Beeri R, Danenberg HD, Planer D, Ben-Dov IZ, Meir K, Sosna J, Lotan C.

Cardiovasc Res. 2008 Aug 1;79(3):492-9. doi: 10.1093/cvr/cvn088. Epub 2008 Apr 5.

16.

Chronic Kidney Disease Impairs Bone Defect Healing in Rats.

Liu W, Kang N, Seriwatanachai D, Dong Y, Zhou L, Lin Y, Ye L, Liang X, Yuan Q.

Sci Rep. 2016 Mar 9;6:23041. doi: 10.1038/srep23041.

17.

Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats.

Arai-Nunota N, Mizobuchi M, Ogata H, Yamazaki-Nakazawa A, Kumata C, Kondo F, Hosaka N, Koiwa F, Kinugasa E, Shibata T, Akizawa T.

PLoS One. 2014 Mar 13;9(3):e91096. doi: 10.1371/journal.pone.0091096. eCollection 2014 Mar 13.

18.

Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats.

Kusano K, Segawa H, Ohnishi R, Fukushima N, Miyamoto K.

J Nutr Sci Vitaminol (Tokyo). 2008 Jun;54(3):237-43.

19.

Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Tomayko EJ, Chung HR, Wilund KR.

J Bone Miner Metab. 2011 Nov;29(6):682-90. doi: 10.1007/s00774-011-0278-4. Epub 2011 Jun 3.

PMID:
21638017
20.

Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.

Arcidiacono MV, Yang J, Fernandez E, Dusso A.

Nephrol Dial Transplant. 2015 Mar;30(3):434-40. doi: 10.1093/ndt/gfu318. Epub 2014 Oct 16.

Supplemental Content

Support Center